Horizon Therapeutics PLC (HZNP) Social Stream



Horizon Therapeutics PLC (HZNP): $90.82

0.39 (+0.43%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Horizon Therapeutics Public Ltd Co (HZNP) Price Targets From Analysts

Use the tables below to see what analysts covering Horizon Therapeutics Public Ltd Co think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-30 9 $155 $107 $134.1 $105.21 27.46%
2021-12-08 10 $155 $107 $134.363 $105.21 27.71%
2022-01-06 10 $156 $107 $135.272 $105.21 28.57%
2022-01-18 10 $155 $107 $135.09 $105.21 28.4%
2022-03-01 10 $155 $107 $134.181 $105.21 27.54%
2022-03-02 10 $155 $107 $134.636 $105.21 27.97%
2022-03-15 11 $155 $121 $137.727 $105.21 30.91%

The Trend in the Analyst Price Target


HZNP's average price target has moved up $23.55 over the prior 43 weeks.

Over the past 49 weeks, HZNP's average upside potential has been 27.65%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-03 7 125 88 114.000 90.50 25.97%
2021-06-26 7 125 88 114.180 95.92 19.04%
2021-07-03 7 125 88 114.180 95.87 19.1%
2021-08-05 12 141 96 124.600 106.37 17.14%
2022-03-01 10 155 107 134.181 97.07 38.23%

HZNP Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.05 10 1 0 0 0 11

The Trend in the Broker Recommendations


HZNP's average broker recommendation rating improved by 0.48 over the prior 35 weeks.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for HZNP as an investment opportunity.

  • In terms of how Horizon Therapeutics Public Ltd Co fares relative to all US stocks, note that its average analyst price target is higher than 648.19% of that group.
  • Horizon Therapeutics Public Ltd Co's upside potential (average analyst target price relative to current price) is higher than 104.58% of Pharmaceutical Products stocks.
  • In terms of how Horizon Therapeutics Public Ltd Co fares relative to Pharmaceutical Products stocks, note that its number of analysts covering the stock is greater than 642.3% of that group.
  • In the context of Pharmaceutical Products stocks, Horizon Therapeutics Public Ltd Co's variance in analysts' estimates is lower than -122.54% of them.

Stocks similar to Horizon Therapeutics Public Ltd Co in the Pharmaceutical Products industry regarding analyst recommendations and price targets are GSK, GRFS, and GMAB.

Is HZNP a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 1.1794 seconds.